Sylke Poehling first Professor of Practice at D-BSSE
Sylke Poehling, Global Head and Senior Vice President for Therapeutic Modalities at Roche Pharma Research & Early Development (Roche pRED) and Member of the Supervisory Boards of Roche Diagnostics GmbH and Roche Deutschland Holding GmbH, has been appointed the first Professor of Practice at our department. A warm welcome, Sylke!
Sylke Poehling has more than 25 years of experience in the biotechnology and pharmaceuticals sector and has contributed to groundbreaking innovations and numerous achievements in pharmaceutical research. She will strengthen the cooperation between higher education and industry, while also driving forward the close exchange in science and teaching between ETH Zurich and Roche pRED as part of the joint postdoctoral programme.
The title "Professor of Practice" was introduced by the ETH Executive Board on 1 January 2023. It is awarded to selected business leaders who have proven expertise and a broad range of experience that contributes to the expansion of practice-oriented study programmes and promotes the transfer of knowledge between science and industry.
Find external page media release of the ETH Executive Board.